 Ketotifen Fumarate |
| Temocapril HCl |
| Fosinopril Sodium |
| Benazepril Hydrochloride |
| Eprosartan |
| 3-Trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-apyrazine Hydrochloride] |
| Mitomycin C |
| Bleomycin sulfate |
| Doxorubicin HCl |
| Epirubicin HCl |
| IdarubicinHCl |
| Fludarabine phosphate |
| MAP |
| 6,7-dihydro-6-mercapto-5h-pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride |
| Imatinib Mesylate |
| Imatinib base |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine |
| 4-(Chloromethyl)benzoic acid |
| Rocuronium Bromide intermediate |
| Voriconazole intermediate |
| Entecavir |
|
|
| Products |
CAS No. |
Specification |
| Ketotifen Fumarate | 34580-14-8 | EP6.2 |
| Temocapril HCl | 110221-44-8 | In-house Standard |
| Fosinopril Sodium | 88889-14-9 | USP31 |
| Benazepril Hydrochloride | 86541-74-4 | USP31 |
| Eprosartan | 144143-96-4 | In-house Standard |
| 3-Trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-apyrazine Hydrochloride] | 762240-92-6 | In-house Standard |
| Mitomycin C | 1950-7-7 | USP31 |
| Bleomycin sulfate | 9041-93-4 | USP31 |
| Doxorubicin HCl | 25316-40-9 | USP31 |
| Epirubicin HCl | 56390-09-1 | USP31 |
| IdarubicinHCl | 57852-57-0 | USP31 |
| Fludarabine phosphate | 75607-67-9 | In-house Standard |
| MAP | 90776-59-3 | In-house Standard |
| 6,7-dihydro-6-mercapto-5h-pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride | 153851-71-9 | In-house Standard |
| Imatinib Mesylate | 220127-57-1 | In-house Standard |
|
|
|
